mGluR2 NAM
Preclinical data suggest that mGluR2 inhibition may have potential for the treatment of Alzheimer's disease and depression. Addex is optimizing multiple series of mGluR2 NAM. This program is available for partnering.
Back to pipeline
Preclinical data suggest that mGluR2 inhibition may have potential for the treatment of Alzheimer's disease and depression. Addex is optimizing multiple series of mGluR2 NAM. This program is available for partnering.
Back to pipeline